Characterization of the chromosomal cephalosporinases produced by Acinetobacter lwoffii and Acinetobacter baumannii clinical isolates

被引:38
|
作者
Perilli, M
Felici, A
Oratore, A
Cornaglia, G
Bonfiglio, G
Rossolini, GM
Amicosante, G
机构
[1] UNIV AQUILA, FAC MED & CHIRURG, DIPARTIMENTO SCI & TECNOL BIOMED & BIOMETRIA, CATTEDRA CHIM BIOL, I-67010 COPPITO, LAQUILA, ITALY
[2] UNIV CATANIA, INST MICROBIOL, CATANIA, ITALY
[3] UNIV VERONA, IST MICROBIOL, I-37100 VERONA, ITALY
[4] UNIV SIENA, DIPARTIMENTO BIOL MOLEC, SEZ MICROBIOL, I-53100 SIENA, ITALY
关键词
D O I
10.1128/AAC.40.3.715
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The beta-lactamases produced by Acinetobacter Iwoffii ULA-501, Acinetobacter baumannii ULA-187, and A. baumannii AC-14 strains were purified and characterized, and their kinetic interactions with several beta-lactam molecules, including substrates and inhibitors, were studied in detail. The three enzymes appeared to be cephalosporinases with different acylation efficiencies (k(cat)/K-m ratio values), and their hydrolytic activities were inhibited by benzylpenicillin, piperacillin, and cefotaxime, which did not behave as substrates. Carbenicillin was a substrate for the beta-lactamase from A. lwoffii ULA-501, whereas it acted as a transient inactivator of the enzymes produced by the two A. baumannii strains. Clavulanic acid was unable to inactivate the three beta-lactamases, whereas sulbactam behaved as an inactivator only at a high concentration (1 mM) which is difficult to achieve during antibiotic therapy. Analysis of the interaction with 6-beta-iodopenicillanic acid also allowed us to better discriminate the three beta-lactamases analyzed in the present study, which can be included in the group 1 functional class (5).
引用
收藏
页码:715 / 719
页数:5
相关论文
共 50 条
  • [21] Tigecycline heteroresistance and resistance mechanism in clinical isolates of Acinetobacter baumannii
    Jo, J. W.
    Ko, K. S.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 58 : 56 - 56
  • [22] Antimicrobial Susceptibilities of Clinical Acinetobacter baumannii Isolates With Different Genotypes
    Altun, Hatice Uludag
    Yagci, Server
    Bulut, Cemal
    Sahin, Hunkar
    Kinikli, Sami
    Adiloglu, Ali Kudret
    Demiroz, Ali Pekcan
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2014, 7 (12)
  • [23] Tigecycline heteroresistance and resistance mechanism in clinical isolates of Acinetobacter baumannii
    Jo, J. W.
    Ko, K. S.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2021, 58 (41) : 56 - 56
  • [24] Tigecycline Heteroresistance and Resistance Mechanism in Clinical Isolates of Acinetobacter baumannii
    Jo, Jeongwoo
    Ko, Kwan Soo
    MICROBIOLOGY SPECTRUM, 2021, 9 (02):
  • [25] Resistance to disinfectants in epidemiologically defined clinical isolates of Acinetobacter baumannii
    Wisplinghoff, H.
    Schmitt, R.
    Woehrmann, A.
    Stefanik, D.
    Seifert, H.
    JOURNAL OF HOSPITAL INFECTION, 2007, 66 (02) : 174 - 181
  • [26] Detection of colistin sensitivity in clinical isolates of Acinetobacter baumannii in Iran
    Vakili, Bahareh
    Fazeli, Hossein
    Shoaei, Parisa
    Yaran, Majid
    Ataei, Behrooz
    Khorvash, Farzin
    Khaleghi, Moj
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2014, 19 : S67 - S70
  • [27] Investigation of Fluoroquinolone Resistance Mechanisms in Clinical Acinetobacter baumannii Isolates
    Guler, Gulsah
    Erac, Bayri
    MIKROBIYOLOJI BULTENI, 2016, 50 (02): : 278 - 286
  • [28] In vitro activity of doripenem against Acinetobacter baumannii clinical isolates
    Marti, Sara
    Sanchez-Cespedes, Javier
    Alba, Veronica
    Vila, Jordi
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 33 (02) : 181 - 182
  • [29] Draft Genome Sequences of 11 Clinical Isolates of Acinetobacter baumannii
    Higgins, P. G.
    Chan, J. Z. -M.
    Seifert, H.
    Pallen, M. J.
    Millard, A. D.
    GENOME ANNOUNCEMENTS, 2016, 4 (02)
  • [30] Antimicrobial resistance of clinical isolates Acinetobacter baumannii in a university hospital
    Stoeva, T.
    Savov, E.
    Bojkova, K.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 29 : S616 - S616